According to the latest disclosure, WuXi Biologics (02269) increased its issued ordinary shares from 4,117,744,981 to 4,128,113,981 as of November 28, 2025. The change involved the exercise of share options under the company’s Pre-IPO Share Option Scheme adopted on January 5, 2016 (amended on August 10, 2016).

On November 27, 2025, 165,000 new shares were issued at HKD1.74. On November 28, 2025, 145,000 new shares were issued at HKD1.48, and an additional 10,059,000 shares were issued at HKD1.29. The transactions were duly authorized by the company’s board and complied with all relevant requirements. The final total of issued shares stands at 4,128,113,981.